Decorative Graphic
Important Notice
This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
Decorative Graphic
Venous
Thromboembolism
+ Cancer
CANCER AND THE RISK OF BLOOD CLOTS
Research has shown that there is a strong connection between cancer and VTE. Genetic changes that cause cancer and many chemotherapy drugs are thought to contribute to the increased risk of VTE in patients with cancer.
Patients with cancer are 5X more likely
to develop a blood clot.1
UNDERSTANDING BLOOD CLOTS
A blood clot in one of the large veins, usually in a person’s leg or arm, is called deep vein thrombosis, or DVT. When a DVT forms, it can partially or completely block the flow of blood through the vein. If DVT is not treated, the clot can break off and travel to the lungs, causing a PE.
A blood clot in the lungs is called pulmonary embolism, or PE. This requires immediate medical attention because a PE can be deadly.
WHY DO PEOPLE WITH
CANCER HAVEA HIGHER RISK FOR BLOOD CLOTS?
More than 900,000 people in the United States get blood clots each year, but patients with cancer
are amongst the most at risk for developing a blood clot. Some of the reasons for this are:
1 in 5
  • The genetic changes that cause cancer and the drugs used to fight cancer can increase the activity of clotting factors in the blood.
  • Tissue damage that can be caused by cancer may start the blood clotting process.
Certain types of cancers can also increase a patient’s risk for blood clots, including:
  • Acute Leukemia
  • Glioblastoma
  • Kidney cancer
  • Lung cancer
  • Pancreatic cancer
  • Metastatic cancer (cancer that has spread from where it started to other areas)
Learn more about the risk factors for blood clots
HOW CAN I PROTECT MYSELF FROM A BLOOD CLOT WHILE BEING TREATED FOR CANCER?
  • Become familiar with the signs and symptoms of blood clots
  • Consider your elevated risk factors (type of cancer, type of cancer treatment)
  • Consult with your doctor to create a blood clot prevention plan
Where can I learn more about cancer and blood clots?
American Cancer Society, National Blood Clot Alliance
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment.

Sources:

1. Fennerty, A. Venous thromboembolic disease and cancer. Postgraduate Medical Journal 2006 Oct; 82:642-648.
2. CDC: https://www.cdc.gov/ncbddd/dvt/materials/cancer-and-blood-clots.html

FlowTriever indications for use:
The FlowTriever Retrieval/Aspiration System is indicated for: (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever Retrieval/Aspiration System is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism.

CONTRAINDICATIONS
  • Not intended for use in the cerebral, carotid, or coronary arteries
  • Not intended for use in endarterectomy procedures or vessel dilation
  • Not indicated for the removal of fibrous, adherent, or calcified material (e.g., atherosclerotic plaque)
  • Not intended for use in vessels < 6 mm
  • Not intended for use with power injector

WARNINGS
  • Intended for single use only. Do not re-sterilize or reuse this device. Reprocessing and re-sterilizatio increase the risks of patient infection and compromised device performance.
  • Should be used in conjunction with fluoroscopic guidance and proper anticoagulation agents
  • Examine the devices before use to verify they are not damaged
  • Use before the "Use By" date specified on the product packaging
  • Excess pressure may result in catheter damage or patient injury
  • Avoid using excessive force to advance or retract against resistance. If excessive resistance occurs, retrac and collapse the distal disks into the catheter and remove the device. Excessive force against resistance may result in damage to the device or vessel perforation.
  • In the event of patient deterioration, remove FlowTriever Catheter/Triever Catheter and assess situation
  • Ensure that FlowTriever wireform disks are withdrawn into Triever Guide Catheter prior to removal fro patient to avoid vascular damage.
  • Do not use in blood vessels that have a history of therapeutic irradiation. Vessel perforation may occur

ClotTriever indications for use:
The ClotTriever Thrombectomy System consists of the ClotTriever Catheter and ClotTriever Sheath. The ClotTriever Thrombectomy System is indicated for: (1) The non-surgical removal of thrombi and emboli from blood vessels. (2) Injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The ClotTriever Thrombectomy System is intended for use in the peripheral vasculature including deep vein thrombosis (DVT).

CONTRAINDICATIONS:
  • Not intended for use without anticoagulation.
  • Not intended for use in the cerebral, carotid or coronary vasculature.
  • Not intended for use in the pulmonary arteries.
  • Not intended for use in endarterectomy procedures or vessel dilation.
  • Not indicated for the removal of fibrous, adherent or calcified material (e.g., atherosclerotic plaque).
  • Not intended for use in vessels < 6 mm.
  • Not intended for use with power injectors.

WARNINGS
  • When used in patients with an IVC filter, damage to the filter, the collection bag, or dislodgment of the VC filter, etc. may occur.
  • When the ClotTriever device is in the path of an exposed stent, damage to the stent, the collection bag, or dislodgment of the stent, etc. may occur.
  • Intended for single use only. Do not re-sterilize or reuse this device. Reprocessing and re-sterilization increase the risks of patient infection and compromised device performance.
  • Should be used in conjunction with fluoroscopic guidance and proper anticoagulation agents.
  • Examine the ClotTriever Catheter prior to insertion to verify it is not damaged.
  • Use before the "Use By" date specified on the product packaging.
  • Avoid using excessive force to advance or retract against resistance. If excessive resistance is encountered, retract and collapse the collection bag and coring element into the Outer Catheter
    • and remove the device. Excessive force against resistance may result in damage to the device or vessel.
  • In the event of patient deterioration, remove the ClotTriever System.
  • Ensure that ClotTriever Catheter is withdrawn into the ClotTriever Sheath prior to removal from patient to avoid vascular damage